Evaluation of a new Argovit as an antiviral agent included in feed to protect the shrimp Litopenaeus vannamei against White Spot Syndrome Virus infection

• Published in: PeerJ (San Francisco, CA) Vol. 8; p. e8446
• Main Authors: Romo-Quiñonez, Carlos R, Álvarez-Sánchez, Ana R, Álvarez-Ruiz, Pindaro, Chávez-Sánchez, Maria C, Bogdanchikova, Nina, Pestryakov, Alexey, Mejia-Ruiz, Claudio H
• Format: Journal Article
• Language: English
• Published: United States PeerJ. Ltd 27.02.2020; PeerJ, Inc; PeerJ Inc
• Subjects: AgNps; Agricultural Science; Analysis; Antiviral agents; Aquaculture; Aquaculture industry; Aquaculture, Fisheries and Fish Science; Arthropods; Bioassays; Biological activity; Biotechnology; Decapoda; Feed additive; Genes; Genetic research; Health aspects; Hemocytes; Immune response; Immune system; Infections; Invertebrates; Legal fees; Litopenaeus vannamei; Marine Biology; Mexico; Mortality; Nanoparticles; Pathogenic microorganisms; Pathogens; Povidone; Shrimp; Shrimp culture; Silver; Studies; Time; Toxicity; Transcription; Transcription (Genetics); Virology; Virus diseases; Viruses; White spot syndrome; WSSV; Mexico; AgNps; Feed additive; Shrimp; WSSV
• ISSN: 2167-8359; 2167-8359
• DOI: 10.7717/peerj.8446

In this study, four experimental assays were conducted to evaluate the use of a new silver nanoparticle formulation named Argovit-4, which was prepared with slight modifications to enhance its biological activity against white spot syndrome virus (WSSV) in shrimp culture. The goals of these assays were to (1) determine the protective effect of Argovit-4 against WSSV, (2) determine whether Argovit-4 supplemented in feed exhibits toxicity towards shrimp, (3) determine whether Argovit-4 as antiviral additive in feed can prevent or delay/reduce WSSV-induced shrimp mortality, and (4) determine whether Argovit-4 supplemented in feed alters the early stages of the shrimp immune response. In bioassay 1, several viral inocula calibrated at 7 SID (shrimp infectious doses 50% endpoint) were exposed to 40, 100, 200 and 1,000 ng/SID of Ag and then intramuscularly injected into shrimp for 96 h. In bioassay 2, shrimp were fed Argovit-4 supplemented in feed at different concentrations (10, 100 and 1,000 µg per gram of feed) for 192 h. In bioassay 3, shrimp were treated with Argovit-4 supplemented in feed at different concentrations and then challenged against WSSV for 192 h. In bioassay 4, quantitative real-time RT-qPCR was performed to measure the transcriptional responses of five immune-relevant genes in haemocytes of experimental shrimp treated with Argovit-4 supplemented in feed at 0, 6, 12, 24 and 48 h. The intramuscularly injected Argovit-4 showed a dose-dependent effect (  < 0.05) on the cumulative shrimp mortality from 0-96 h post-infection. In the second bioassay, shrimp fed Argovit-4 supplemented in feed did not show signs of toxicity for the assayed doses over the 192-h experiment. The third and fourth bioassays showed that shrimp challenged with WSSV at 1,000 µg/g feed exhibited reduced mortality without altering the expression of some immune system-related genes according to the observed level of transcriptional. This study is the first show that the new Argovit-4 formulation has potential as an antiviral additive in feed against WSSV and demonstrates a practical therapeutic strategy to control WSSV and possibly other invertebrate pathogens in shrimp aquaculture.